|
⚲
|
| Keyboard |
| Wapnick Pamela
✚
|
|
|---|---|
| CIK # | 0001995657 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001995657] | |
| 4 | [0001995657] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Metagenomi Therapeutics Inc | |
| Wapnick Pamela |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2026-03-05 | Sell | 1,581 | $1.60 | 2,530 |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2025-12-05 | Sell | 1,576 | $1.77 | 2,790 |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2025-12-01 | Grant | 120,000 | $1.60 | 192,000 |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2025-09-05 | Sell | 1,576 | $1.81 | 2,853 |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2025-06-06 | Sell | 1,576 | $1.75 | 2,758 |
|
Metagenomi Therapeutics Inc MGX
Stock Option (Right to Buy) · derivative
|
2025-04-01 | Grant | 84,000 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2025-04-01 | Grant | 14,000 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2025-03-05 | Sell | 1,808 | $1.87 | 3,381 |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2024-12-05 | Sell | 1,559 | $1.86 | 2,900 |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2024-09-05 | Sell | 6,265 | $2.88 | 18,043 |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2024-04-01 | Grant | 69,316 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Stock Option (Right to Buy) · derivative
|
2024-04-01 | Grant | 291,450 | $0.00 |